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Sleep disturbance is commonly encountered amongst intensive care patients and has significant psychophysiological
effects, which protract recovery and increases mortality. Bio-physiological monitoring of intensive care patients reveal
alterations in sleep architecture, with reduced sleep quality and continuity. The etiological causes of sleep disturbance
are considered to be multifactorial, although environmental stressors namely, noise, light and clinical care interactions
have been frequently cited in both subjective and objective studies. As a result, interventions are targeted towards
modifiable factors to ameliorate their impact. This paper reviews normal sleep physiology and the impact that
sleep disturbance has on patient psychophysiological recovery, and the contribution that the clinical environment
has on intensive care patients’ sleep.
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Introduction
Sleep is considered to be an essential biological function
to maintain physiological and emotional wellbeing. How-
ever, sleep in the intensive care unit (ICU) has been re-
ported by survivors of critical illness to be of a poor
quality and a major stressor associated with their admis-
sion [1]. The proclivity for sleep and circadian disturbance
amongst ICU patients has been attributed to the intrusive
clinical care and clinical environment, with environmental
factors inclusive of noise, and light as etiological causes.
As a result, patients exhibit symptoms consistent with
dyssomnia, such as difficulty with sleep initiation and frag-
mentation, and early morning awakenings [2]. This paper
discusses the impact of environmental factors: noise, light
and clinical care interactions on patient sleep and the psy-
chophysiological consequences of sleep disturbance.Normal sleep architecture
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of three stages which constitutes between 75% to 80% of
the total sleep time (TST) [3] with the first stage (N1)
acting as a transition between wakefulness and deep
sleep. N1 is characterised by physical drowsiness, com-
bined with decreased ocular movements and a reduction
in muscle activity [3,4]. This is followed by N2, in which
the individual becomes decreasingly unaware of their
surroundings, yet remains easily roused by noise [5]. As
sleep progresses, N2 becomes the predominant stage
making up 45% to 55% of the NREM phase.
Stage N3 consists mostly of slow wave activity and is
considered to be an anabolic and physically restorative
stage [6]. This stage is prominent in the first third of the
night’s sleep and is deemed to be the deepest and most
restful stage of the sleep cycle. During slow wave sleep
(SWS), metabolic activity is at its lowest leading to a
reduction in oxygen consumption. Growth hormone is
secreted during this stage which promotes protein syn-
thesis, tissue healing and physical recovery [7]. In con-
trast, the proceeding REM phase features increased
cerebral and physiological activity, whereby the brain’s
metabolic rate reflects that of a wakeful state with bursts
of REM, coupled with skeletal muscle atonia [3,8-10].
The time spent in REM sleep increases over the lengthan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Whilst REM sleep contributes to a restful night sleep,
this phase has a lower threshold for awakening than
SWS.
The onset of oneiric phenomena has traditionally been
associated with REM sleep; however neurophysiological
research indicates that dreaming occurs in both REM
and NREM phases [11,12]. The occurrence of oneiric ac-
tivity between the phases have some qualitative variances
with dream activity during NREM sleep being associated
with memory processing and recall of experiences,
whilst in REM sleep it is characterised by visuohallucina-
tory and unusual content [13]. The role of dreaming is
thought to have importance for cognition, associated
with mental processing and memory consolidation.
Sleep disturbance in ICU
The sleep physiology of ICU patients indicates that
whilst their TST is often normal (7 to 9 h) [2,14-17],
sleep is highly fragmented with patients experiencing 6.2
awakenings per hour [2]. Sleep quality is further com-
promised as the majority of sleep is spent in stages N1
and N2 which is perceived to be ‘light sleep’ with limited
restorative benefits. Subsequently, the characteristics of
non-consolidated light sleep have resulted in ICU pa-
tients being sleep deprived. This has been attributed to a
reduction in the duration of REM sleep and SWS, the
supposition is that these phases support restorative pro-
cesses and are important for recovery [16,18]. Due to a
lack of quality sleep, patients experience daytime somno-
lence, with as much as 50% of patient TST occurring
during daylight hours [15,16,19,20]. Sleep cycles which
traverse both day and night perpetuate the phase shifting
of circadian rhythms with sleep disturbance persisting
months after discharge from ICU [21].
The impact of severity of illness on sleep architecture
and sleep disturbance has been widely considered; how-
ever, there are limited studies explicitly investigating this
factor. There exists some clinical indication that higher
acuity scores are associated with greater sleep disturb-
ance, specifically increased fragmentation and number of
awakenings [22]. Gabor et al. [15] reported that healthy
participants exposed to the ICU environment compared
to ICU patients did not demonstrate the same level of
sleep disturbance and reduction in SWS, suggesting that
critical illness may be a contributing factor to the abnor-
malities seen in the sleep architecture of ICU patients.
However, in this study, the healthy participants were
only exposed to the noise within the environment and
not to the full sensory experience of ICU such as frequent
clinical interactions and invasive monitoring. Further, pa-
tients with higher acuity score also demonstrate consider-
able reduction in the EEG activity, which confounds the
ability to accurately interpret polysomnographical data.Problematic to the investigation of severity of illness on
sleep is the numerous contributing factors such as mech-
anical ventilation, pain, pharmacological agents and the
greater need for clinical interventions, which confound
the ability to determine causality.
Physiological effects of sleep disturbance
Physiologically, sleep deprivation has a myriad of nega-
tive cognitive, autonomic [23], metabolic [24,25] and
hormonal [7,26,27] effects on the body that may contrib-
ute to prolonged ICU admission and in turn may con-
tribute to an increase in patient morbidity. Findings
derived from animal-based studies reveals that sleep
deprivation is associated with increased mortality; the
implications of such findings within the ICU setting have
the capacity to be profound as sleep disturbance is com-
monly experience by this patient cohort [27,28].
Effects on the respiratory system
The chemosensitivity of the brain’s respiratory centre is
reduced amongst sleep-deprived patients, with White
et al. [29] reporting a decrease in intrinsic ventilatory re-
sponse to hypoxic and hypercapnic states. Further, stud-
ies have reiterated varying adverse effects of sleep
deprivation on respiratory muscle function including
Phillip et al. [30] who demonstrated a significant reduc-
tion in FEV1 (mean decline of 6%) and FVC (mean de-
cline of 5%) in sleep-deprived patients with underlying
chronic obstructive pulmonary disease (COPD) com-
pared to non-sleep-deprived COPD patients. Further-
more, maximal inspiratory pressure (MIP) was found to
decrease from 81.5 ± 8.8 cmH2O in rested individuals to
75.9 ± 7.6 cmH2O in those who were sleep deprived
[30]. Issues associated with inspiratory muscle endur-
ance has also been reported by Cheng and Tang [31],
who found that sleep deprivation amongst healthy indi-
viduals resulted in a significant decline in respiratory
muscle strength. Findings such as these suggest that sleep-
deprived states may contribute to patient hypoventilation,
adversely effecting pulmonary reserves and overall readi-
ness and ability to expedite weaning from mechanical
ventilation.
Effects on the cardiovascular system
The manifestation of cardiovascular effects of sleep
deprivation emanates from the stimulation of the sym-
pathetic nervous system (SNS) and the release of the
catecholamines adrenaline and noradrenaline. As a re-
sult, increases in blood pressure and heart rate are re-
ported due to changes in baroreflex sensitivity [32-34].
Ogawa et al. [33] reported that increased baroreflex
results in a 12 mmHg elevation in blood pressure as a
result of a single night’s sleep deprivation amongst
healthy individuals.
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Neuro-immunological research asserts that there exists a
bidirectional relationship between sleep deprivation and
the immune system. Although the vast majority of stud-
ies conducted are animal based, the reported changes
identified in the immunological system in response to
sleep deprivation can have significant implications for
critically ill patients.
The adaptive immune response and the functioning of
the T cells have been reported to be vulnerable to sleep
disturbance, as studies have identified that sleep plays an
important role in the extravasation of the T cells [35,36].
The resulting increase in the propensity for sleep during
illness may play an important role in promoting the
function of the immune response and overall recovery.
Previous animal studies have identified that interleukin
(IL)-1 and tumour necrosis factor (TNF) contribute to
an increase in non-REM sleep and sleep fragmentation
[37]. This occurs as immunoreactive neurons of the cy-
tokines which are located in regions of the brain that
play a role in the sleep-wake cycle. Although the re-
ported propensity for sleep during critical illness remains
unknown, it is hypothesised that the role of IL-1 and its
interaction with 5-hydrotryptamine (5-HT) may proffer
an explanation. The onset of fever in response to
invading pathogens potentiates the immune response
and promotes survival. The resulting increase in pro-
inflammatory cytokines such as IL-1 impacts on the
sleep architecture through increasing the NREM phase
with greater fragmentation and reducing REM sleep;
these effects, however, allow for an enhanced inflamma-
tory response [38-40]. The increased NREM sleep is
thought to be an important aspect that supports the on-
set of fever; as during this phase the brain and body
temperature is reduced, along with metabolic activity
[37]. These features of the NREM stage allow for en-
hance heat dissipation with the corresponding increase
in sleep fragmentation further facilitates heat loss [37].
Furthermore, the function of natural killer (NK) cells
has been shown to be adversely effected in sleep-
deprived states, although research findings have not al-
ways been consistent. Irwin et al. [41] found that the
functionality of NK cells was reduced by 30% in sleep-
deprived states in healthy subjects. This was further reit-
erated in their 1996 study which demonstrated that
whilst NK cell activity initially declined, it did improve
after sleep recovery. In contrast, Dinges et al. [42] re-
ported that NK cell activity was increased in healthy
adults who were sleep deprived; however, leukocyte
function was suppressed. Although much of the research
investigating the relationship between immune function
and sleep deprivation has been conducted on healthy in-
dividuals, it is apparent that sleep provides an important
role in the effective functioning of the immune system.Effects on the metabolic system
During nocturnal sleep, downregulation occurs in the
hypothalamus-pituitary-adrenal (HPA) axis and the SNS,
which both have important roles in stress responses.
Ensuing is a decrease in noradrenaline, adrenaline and
cortisol levels which suppresses the immune systems
anti-inflammatory cytokines [43]. During sleep, particu-
larly SWS, growth hormone is released in combination
with prolactin and leptin which provide pro-inflammatory
signals which triggers the immune system activation [44].
The HPA axis plays an integral role in the body’s response
to stress, primarily via the release of cortisol. Abnormal
cortisol levels in ICU patients contribute to further distur-
bances with circadian rhythms, as cortisol release is
normally increased prior to waking to stimulate the in-
dividual into a state ready to be active. An increase in
cortisol levels and suppression of melatonin produces
a propensity for patients to be in a wakeful state which
may further exacerbate catabolic activity and increases
oxygen consumption.
Sleep disturbance adversely effects carbohydrate metab-
olism resulting in insulin resistance and glucose clearance.
Whereby, the increase in SNS activity and the ensuing
stress response suppresses the release of insulin from pan-
creatic beta cells [45,46]. The impact of this on healthy in-
dividuals is an increased susceptibility to chronic health
conditions such as coronary artery disease and diabetes.
Within the ICU patient population, this can exacerbate
underlying co-morbidities, putting them at risk for add-
itional secondary complications. For example, instability
in blood glucose levels has been associated with increased
patient mortality [47]. The immunological effects of sleep
disturbance also have a concomitant effect on metabolic
functions with pro-inflammatory cytokines increasing in
activity with moderate total sleep loss, which contributes
to insulin resistance [44].
Effects on the neurocognitive system
The onset of delirium amongst ICU patient ranges be-
tween 60% to 80% for mechanically ventilated patients
and 20% to 50% for non-mechanically ventilated patients
[48,49]. Delirium has been identified as an independent
predictor for adverse patient outcomes including increased
hospital length of stay, a persistent decline in cognitive
status and increased patient mortality [48-50].
A number of factors have been purported to contribute
to the development of delirium, with sleep deprivation
thought to be a contributing factor. However, the rela-
tionship is not clearly understood in regard to whether
sleep deprivation leads to delirium or if the onset of de-
lirium contributes to sleep deprivation. Nonetheless,
sleep deprivation and delirium share a number of similar
features namely a decline in cognitive function inclusive
of psychomotor vigilance, memory and disturbances in
Table 2 Factors impacting on sleep architecture
Factor Example
Environmental noise Staff conversations and monitoring
alarms
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nations and delusions [51,52]. Although recommendations
aimed at minimising the likely onset and complications
associated with delirium include reducing sleep disturb-
ance, one of the major challenges is associated with the
pharmacological agents used to treat symptoms associated
with delirium. Many of the pharmacological agents such
as haloperidol and benzodiazepines used can potentially
exacerbate sleep disturbance, due their inhibitory effect on
SWS and REM sleep [52].
Commonly used GABA agonists such as propofol and
benzodiazepines (Table 1) increase total sleep time and
decrease sleep latency; however, these decrease N3 and
REM sleep stages [53,54]. The pharmacokinetics of these
medications suppresses cerebral function which pro-
duces changes in EEG activity such as a reduction in
delta activity [55]. Similarly, commonly used opioids,
morphine and fentanyl, increase total sleep time, they
adversely impact N3 and inhibit REM sleep [56]. Al-
though sedation and analgesia is commonly required to
support therapies such as mechanical ventilation and
promote patient comfort, understanding the cumulative
effects of commonly used pharmacological agents and
identifying newer emerging medications that may reduce
the negative effects on sleep is an area for further re-
search. Preliminary animal-based research regarding the
effective of dexmedetomidine indicates that it increases
N3 sleep, whilst ICU-based research suggests that inci-
dences of delirium onset maybe reduced [57]. These
preliminary findings suggest the dexmedetomidine
may have an important role in the management of crit-
ically ill patients, which may reduce the incidences of
delirium and the degree of sleep disturbance experi-
ence by patients.
The impact that traumatic brain jury (TBI) has on
sleep can be profound. The prevalence of TBI ranges be-
tween 30% and 84% and makes up a large percentage of
critical care admissions [58,59]. In the acute phase of
presentations, the impact that pharmacological agentsTable 1 The effect of pharmacological agents on sleep
Pharmacological agent TST SWS REM
Propofol ↑ ↓ ↓
Lorazepam ↑ ↓ ↓
Alprazolam ↑ ↓ ↓
Diazepam ↑ ↓ ↓
Haloperidol ↑ ↑ ↓
Morphine ↓ ↓ ↓
Fentanyl ↑ ↓ ↓
Midazolam ↑ ↓ ↓
Dexmedetomidine ↑ ↑ ↓
TST, total sleep time; SWS, slow wave sleep; REM, rapid eye movement;
↑, increase; ↓, decrease.combined with increased intra-cranial pressure can se-
verely affect cerebral functioning and neurotransmitter
activity resulting in decreased EEG activity. Sleep dis-
turbance within this patient cohort may have significant
implications for recovery outcomes, with previous re-
search indicating that the presence of SWS and REM
sleep, along with sleep efficiency correlated to improved
cognitive outcomes [60]. The negative effects that TBI
has on sleep can persist for months after ICU discharge
and are predominantly associated with sleep initiation
and maintenance and sleep architecture which can ad-
versely affect cognition and behaviour [61,62].
Environmental factors impacting of ICU patients sleep
The importance of sleep in patient recovery can be
deprioritized in ICU due to the need to meet increas-
ingly complex care requirements. Sleep disturbance has
emerged as an indicator for adverse clinical outcomes
[52,63] and in turn should not be viewed as a passive
physical state but rather acknowledged as an important
bio-physiological process. The impact of the ICU environ-
ment on patient sleep has been frequently reported on
and investigated as a primary etiological cause of sleep dis-
turbance. Factors such as light, noise, clinical care-related
interactions, combined with medications and acute illness
have all been hypothesised as causal factors for sleep
deprivation [1,2,7,15,16,19,64,65] (Table 2).
Effects of noise levels
Noise levels in ICU have been presumed to be the most
disruptive environmental stressor that patients are sub-
jected to and are a relentless feature due the cacophony
of clinical activity and technological monitoring. Noise is
defined in terms of mechanical energy and is commonlyProlonged exposure to low
levels of artificial light
Inflammatory mediators
Pain
Pharmacological agents Sedative, opioids, benzodiazepines
and inotropes
Mechanical ventilation
Increased cortisol release
Decreased endogenous
melatonin levels
Critical illness
Clinical interactions Vital sign monitoring, pathological
investigations and medication
administration
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accurately attenuates the noise levels heard by the hu-
man ear [66]. The measure of decibels is logarithmic,
and as a result, a 10-dB increase in noise constitutes a
doubling of the noise level [67].
The World Health Organisation (WHO) recommends
that noise levels within hospital wards should not exceed
30 dB(A) at night in order to reduce sleep disturbance
[68]. The ability for ICUs to meet the WHO recommen-
dations is improbable and is further reiterated within the
literature whereby ICUs worldwide repeatedly cite noise
levels in excess of 50 dB [2,64,65,69-71]. Moreover, noise
levels in ICUs have steadily increased over the past de-
cades, with a study conducted by Busch-Vishnich [72]
quantifying this at a rate of 0.38 dB(A) per day and 0.42
dB(A) per night, per year. The evolving advances in
medical care, technology and increasing patient acuity
are contributing factors to the acoustical changes within
the clinical environment. The noise generated from alarms
associated with the intensive monitoring of patients fre-
quently exceeds 70 dB(A), which is reflective of the noise
generated by traffic [73]. Further, with the increasing am-
bient noise level, the impact of the Lombard effect can be
compounded. This communication phenomenon results
in individuals increasing their speech amplitude in order
to enhance the intelligibility of their speech within noisy
environments and contributes to a rapid escalation in
environmental noise. This creates an environment that
is detrimental to patients’ sleep as noise levels fre-
quently undulate between low levels, with frequent
short, sharp and unpredictable escalations in noise [74].
Both subjective and objective studies have reported
noise as a primary source of sleep disturbance, with staff
being the primary source of the generated noise [15,16,75].
Subjective studies investigating the impact of noise on sleep
indicate that ICU patients identify the exposure to noise
and inability to sleep as a major stressor recounted by
patients. Further, objective studies indicate that the
noise generated with within the environment is not con-
ducive to the ability to sleep. The primary source of
noise within the clinical environment has been attrib-
uted to staff behaviours, which Kahn et al. [76] reported
accounted for greater than 50% of noise sources with an
average noise level of 84 dB. Previous studies have sug-
gested that the disruptive nature of staff behaviours
evolve from the propensity of staff to deprioritized
sleep, due to patients being intubated and sedated, and
lacked knowledge regarding the psychophysiological ef-
fects of sleep deprivation [70,77]. As a result of subject-
ive studies, behaviour modification strategies have been
widely investigated as a means to curtail the impact of
noise generated by staff on patient sleep and have been
cited as being successful in reducing noise levels by 6%
to 20% [78-80]. These behaviour modification activitieshave primarily involved an educational approach to en-
hance staff awareness of the impact their behaviours
have in contributing to noise levels and promoting re-
ductions in alarm volume settings to promote a diur-
nally appropriate environment. However, these studies
have employed subjective assessments of the impact of
behaviour modification, such as clinical staff perception
of nocturnal noise, as opposed to using an objective en-
vironmental measure of noise. This has been problem-
atic as studies that have employed environmental noise
monitoring to determine the effect of behaviour modifica-
tion on noise have been unable to achieve a measurable
reduction in noise levels [81]. Furthermore, achieving sus-
tainable change in the clinical environment has not been
extensively investigated as behaviour modification studies
have been undertaken over short durations, with follow-
up assessments conducted after the immediate interven-
tion period.
Studies employing objective measures of sleep have re-
ported varying results. Aaron et al. [75] investigated the
impact of noise on sleep via polysomnography (PSG)
and reported that noise sources exceeding 50 dB(A) re-
sulted in electroencephalographic changes indicative of
arousal in 25% of cases. However, this finding has not
been consistently reported in proceeding studies; further,
there is a discrepancy between self-reported sleep quality
and the biophysiological data obtained regarding sleep.
Studies employing time synchronised monitoring of
sleep via polysomnography and environmental noise
monitoring, such as Freedman et al. [16] identified that
only 11.5% of arousals and 17% of awakenings could be
attributed to noise. Likewise, in a similar study, Gabor
et al. [15] identified that 20% of awakenings were the
direct result of environmental noise. Neither study was
able to account for the cause of the remaining 75% to
80% of arousals but postulated that clinical interactions
may account for much of these. However, this was not
supported by Gabor et al.’s [15] findings, whereby only
7% of awakenings could be associated with clinical inter-
actions. Subsequently, the degree to which noise acts as
the pathogenesis of sleep disturbance in ICU remains
unclear, although it is commonly reported as an issue by
survivors of critical illness.
Effects of clinical interactions
The need for clinical interventions increases exponen-
tially in ICU as many assessments are scheduled on an
hourly basis such as vital sign monitoring, fluid balance
assessments and pharmacological administration. These
interventions in combination with basic care needs es-
tablish an environment in which sleep is easily depriori-
tized and disrupted. Furthermore, the design of ICU can
compound issues, as the clinical area is frequently open
planned with patients segregated from each other by
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the clinical environment on patients’ senses.
Early observational studies conducted by Walker [82]
and Woods [83] reported that patients were disturbed
between 1 and 14 times per hour, and given that a single
sleep cycle requires 90 to 110 min to complete, patients
cared for in the ICU have little ability to achieve quality
sleep. In more contemporary studies such as Lee et al.’s
[84], 50% of subjects reported being woken 2 to 5 times
throughout the night, which contributed to difficulties
falling back to sleep once woken. This finding has been
corroborated by previous studies conducted by Redeker
and Hedges [85] and Tranmer et al. [1]. In contrast,
studies conducted by Tamburri et al. [86] and Celik
et al. [87] report much higher patient to staff interac-
tions with both studies reporting between 40 and 60 in-
teractions per night. Comparatively, the frequency of
disruptions for mechanically ventilated patients was
found to be substantially higher, with Le et al. [88]
reporting that patients experienced 20 to 60 disruptions
per hour.
The intensive monitoring that patients are subjected
to is detrimental to the intrinsic sleep cycle, suggesting
that under these conditions ICU patients will experience
sleep deprivation. Further, in an observational study by
Le et al. [88], nursing staff reported that 13.9% of noc-
turnal interactions could be safely omitted and, in turn,
reduce the disturbance to patients. This suggests that a
number of nursing-based activities are performed as a
routine rather than based on clinical evidence and ne-
cessity. This highlights the need for clinical staff to crit-
ically evaluate the necessity for some of the care
provided and to consider making adjustments to work-
flow in order to promote nocturnal sleep.
Effects of light
Regulation of the circadian rhythm is influenced by so-
called zeitgebers (environmental cues) to remain entrained
to the typical day/night routine. Prominent zeitgebers in-
clude meal times and exposure to daylight, both of which
can be suppressed amongst critically ill patients. Nutrition
is frequently provided enterally on a 24-h continuum,
whilst ICU design and critical illness does not permit pa-
tient exposure to adequate natural light. Subsequently, the
outcome of inappropriately timed zeitgebers in combin-
ation with prolonged exposure to low levels of artificial
lighting can impact on the circadian pacemaker leading to
circadian disturbance.
The protracted exposure to artificial lighting obfus-
cates the normal circadian rhythms, with light levels
within ICUs being highly variable, ranging between a
mean of 5 and 1,400 Lux. Exposure to low levels of arti-
ficial light less than 500 Lux and for as little as 20 min
has been identified as sufficient to suppress nocturnalmelatonin secretion [89-92]. Melatonin is an important
regulator hormone of the circadian rhythm. Melatonin
levels increase during the early hours of the night to fa-
cilitate the onset of sleep and decrease during the morn-
ing when cortisol levels increase. Whilst there is a focus
on the potential role of melatonin in promoting sleep in
this patient population, subjective studies have reported
that ICU survivors perceived light exposure to be min-
imally disruptive to their ability to sleep [93]. Hu et al.
[94] investigated the effect of non-invasive, non-
pharmacological interventions of ear plugs and eye
masks on ICU patients (n = 14) who underwent PSG
sleep monitoring. The study found that these interven-
tions resulted in an increase in recorded REM sleep, a
reduction in REM latency with less arousals (p < 0.05)
and an elevation in melatonin levels (p =0.002). Suggesting
that although patients may not perceive exposure to light
a major cause of sleep disturbance, it appears to have a
detrimental effect of sleep wake patterns, and simple inter-
ventions may be able to minimise its effects.
A considerable body of research focuses on how light
exposure affects endogenous melatonin secretion and
the potential efficacy of supplemental melatonin as a
means to entrain the circadian rhythm and overcome
the lack of light variation to maintain the external zeit-
geber. Munigler [95] reported that melatonin secretion
was suppressed in patient with sepsis compared to non-
septic ICU patients who demonstrated normalised circa-
dian patterns similar to healthy individuals. In a double
blind placebo controlled study (n = 8), patients receiving
supplemental melatonin demonstrated an improvement
in sleep duration and sleep quality [96]. In contrast, a
study conducted by Egi et al. [97] involving 32 tracheos-
tomised ICU patients was inconclusive regarding the
benefits of melatonin in promoting sleep, finding that al-
though melatonin levels increased in the treatment
group it did not result in improved observable nocturnal
sleep (240 min versus 243.4 min in the placebo group).
A similar study undertaken by Bourne et al. [98] also
studied the effect of supplemental nocturnal (21:00 h)
melatonin administration of 10 mg in 27 ICU patients
who had undergone trachesotomy insertion to promote
ventilator weaning. The reported outcome of this study
was that sleep in the treatment group increased by 1 h
(sleep efficiency index difference = 0.12, 95% CI −0.02 to
0.27, p = 0.04) compared to the placebo group, along
with an objective improvement in sleep quality as evalu-
ated by bispectral index (BIS).
Melatonin has emerged as a possible treatment to
maintain the circadian rhythm with oral administration
having good bioavailability, with minimal negative effects
on respiration despite its hypnotic effects [99]. To date,
the studies conducted have involved small participant
numbers and variances in sleep assessment. Future studies
Table 3 Interventions to reduce sleep disturbance
Intervention Example
Establish a nocturnal environment By reducing volumes of
alarms and phones.
Enhance staff awareness of noise
produced by conversations
Soundear
Employ the use of night settings in
monitoring equipment with backlighting
to reduce exposure to light.
Judicious use of pharmacological agents
Monitor, assess and treat pain
Devise individualised sleep hygiene routines
Employ relaxation techniques in
preparation for sleep
Music therapy and massage
Decrease environmental stimulus Via the use of eye masks and
ear plugs
Reduce nocturnal clinical interactions Cluster clinical care and
scheduling of procedures
Ventilator support to promote rest
overnight
Reduce daytime napping in order to
reduce circadian dys-synchrony
Promote daytime activity Such as sitting out of bed
and mobilisation
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sleep monitoring via PSG are required to ascertain the
potential of melatonin as a standard therapy, along with
the effect of concurrent interventions such as eye masks
and ear plugs to negate some of the sensory experience
of the ICU environment.
Sleep monitoring techniques
Sleep-related research conducted amongst ICU patients
clearly identifies significant sleep disturbances, which
can have deleterious implications on their psycho-
physiological condition which protract recovery. Des-
pite these findings, there remains no method that is
feasible for widespread implementation that accurately
monitors patients’ sleep within the ICU environment.
Although PSG provides considerable benefits over
other strategies in being able to provide details of sleep
physiology, it is not a strategy that is feasible to be im-
plemented widely as it is expensive, labour intensive
and technically difficult. In comparison, simple cost-
effective methods involving clinical observations are
questionable regarding their accuracy as studies have
indicated that these result in an overestimation of sleep
time and quality [17,65,100]. This was demonstrated by
Nicolas and colleagues’ [8] quantitative single blinded
descriptive study, investigating nursing-based assess-
ment and patient perception of sleep which found that
these correlated only 50% of the time, with nursing staff
overestimating patients’ quality of sleep. Adjunct
methods such as actigraphy (ACTG) have been consid-
ered, although studies involving the ICU are few and
participant numbers are small. There are, however,
some favourable attributes associated with ACTG use
in comparison to PSG in that it is cost effective, is easy
to interpret and is able to collect data over an extended
period. The limitations of ACTG need to be acknowl-
edged in that it will provide no information regarding
the sleep architecture of patients and may be suitable
only for a limited cohort of ICU patients. However, it
may be potentially useful in monitoring circadian dis-
turbance and sleep fragmentation, both of which are
major issues associated with ICU patients. Potentially,
further advancements in monitoring techniques and
the development of advanced monitoring algorithms
may provide clinicians with a viable method.
As a result there is a need to develop accurate and ef-
fective clinical monitoring methods of sleep, to facilitate
the early recognition of sleep disturbance. Interventions
need to be implemented that aim to provide an environ-
ment that supports sleep and recognises its role in pa-
tient recovery (Table 3). Additional research needs to be
undertaken in order to understand the physiological im-
pact of critical illness on patient sleep, the relationship
between delirium and sleep disturbance, along with howmechanical ventilation can be utilised to facilitate nocturnal
rest, and identification of pharmacological agents and
regimes that do not interfere with the intrinsic sleep
cycle. Further, identifying strategies that can be readily
implemented that endeavour to minimise the impact of
complications associated with sleep deprivation. How-
beit, research investigating sleep promotion strategies
have lacked clinical efficacy [17,92,100], as PSG is not
viable for widespread implementation, behavioural assess-
ments such as ACTG have not been able to accurately
assess sleep in critically ill patients, and subjective assess-
ments such as nursing-based observation frequently over-
estimate sleep. Adjunct interventions such as behaviour
modification of staff through education have only been
subjectively evaluated and their impact on the long term is
not evaluated. Emerging benefit of eye masks and ear
plugs may have some benefit in quashing the effect of the
ICU environment on patients but do improve the sleep
architecture of patients. Similarly, melatonin administra-
tion reports some promising benefits; however, larger
studies are required. A primary issue confronting clinicians
regarding sleep in ICU is the development of a method
that allows for sleep monitoring to be implemented as a
standard of clinical care, which provides accurate informa-
tion regarding the sleep of this patient cohort.
Conclusions
Despite decades of research identifying the impact of
the clinical environment on ICU patients’ sleep, little
Delaney et al. Annals of Intensive Care  (2015) 5:3 Page 8 of 10has been accomplished in overcoming the factors that
are purported to contribute to sleep disturbance. There
exists a multitude of factors that contribute to sleep
disturbance that highlights the complexities faced when
attempting to manage sleep disturbance and conse-
quences of sleep deprivation on patient recovery. This
is also inclusive of the intricate impact that severity of
illness has on sleep which is yet to be fully elucidated.
Clinicians involved in the provision of care to patients
need to be attuned and aware of the consequences of
sleep disturbance and how to make modifications to
their environment and care planning in order to pro-
mote sleep and aid recovery. There exists a need to
undertake further clinical research to identify effective
strategies to curtail the impact of the clinical environ-
ment on patients’ ability to sleep and to enhance under-
standing between the impact of sleep deprivation and
patient outcomes. Further, future research should be di-
rected at identifying an accurate and feasible sleep
monitoring method to facilitate the ability to imple-
ment strategies that endeavour to promote sleep and
recovery, whilst decreasing the associated complica-
tions linked to sleep deprivation.
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